Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)

NCT01963260 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenia Purpura

Interventions

DRUG: MK-8723
DRUG: Matching Placebo

Sponsor

Merck Sharp & Dohme LLC